An alum of the Department of Urology Residency Program, he has enjoyed serving patients in the Iowa City area for more than 30 years.

The grant from the U.S. Department of Defense supports ongoing development of an interferon (IFN)-γ targeted therapy to treat chronic pain caused by interstitial cystitis/bladder pain syndrome.

“We have the most advanced early-stage bladder cancer program in the world,” says Dr. Michael A. O'Donnell, who has developed a handful of novel multi-agent chemotherapy regimens for non-muscle invasive bladder cancer.

A new study from the University of Iowa Department of Urology finds that a safe, inexpensive combo-chemotherapy is better tolerated than BCG and is better at preventing high-grade cancer recurrence in patients with non-muscle invasive bladder cancer.

A chemotherapy regimen for high-risk cases of non-muscle invasive bladder cancer has shown promising signs of effectiveness and tolerability.

Taking inspiration from popular gaming devices, the design and engineering experts on the UI Protostudios team are helping pediatric urologist Christopher S. Cooper, MD, devise a bladder pressure monitor that will be easy for kids to operate.